About this page
Insider trades reported on SEC Form 4: when the people who run a company buy or sell its shares with their own money.
How to read it
- Form 4
- The form a company insider (officer, director or owner of more than 10%) must file with the SEC within two business days of buying or selling the company's shares.
- Buy (P) and Sell (S)
- Open-market purchases and sales. Gifts, option exercises and automatic tax withholding are left out because they say little about what the insider thinks.
- Value
- Shares times price, as reported on the filing.
- 10b5-1
- A trade made under a plan set up in advance. Planned sales are common and usually say less than an unplanned purchase.
- Late filing
- A Form 4 filed more than two business days after the trade.
- Vs. S&P 500
- How the stock did after the trade minus how the overall market did in the same weeks.
A real example
In January 2016, when bank stocks were falling, JPMorgan Chase CEO Jamie Dimon bought 500,000 JPMorgan shares with his own money, worth about $26 million. His Form 4 made the purchase public within days, and investors read it as a strong sign of confidence.
Explain it like I'm 13
If the coach of a team bets his own allowance that his team will win, that tells you something. A Form 4 is the note a company boss must hand in whenever he buys or sells his own company's shares, so everyone can see it.
Data from public SEC filings and congressional reports. Information, not investment advice. Check every number against the filing linked on the page.
Pharvaris N.V. (PHVS) Insider Trading
32 open-market trades reported since Jun 17, 2026: 0 purchases worth $0 and 32 sales worth $25.9M.
By insider
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Viviane Monges | Director | 0 | $0 | 1 | $396K |
| Schikan Johannes Gerardus Christiaan Petrus | Director | 0 | $0 | 5 | $8.44M |
| David W. Nassif | CFO | 0 | $0 | 1 | $219K |
| Peng Lu | President | 0 | $0 | 6 | $5.74M |
| Elisabeth Bjork | Director | 0 | $0 | 1 | $1.99M |
| Anne Lesage | Chief Early Development | 0 | $0 | 8 | $4.77M |
| Robert Glassman | Director | 0 | $0 | 3 | $1.19M |
| Stefan Andreas Abele | Chief Technical Ops Officer | 0 | $0 | 1 | $1.77M |
| Wim Souverijns | Chief Commercial Officer | 0 | $0 | 2 | $1.02M |
| Berndt Modig | CEO | 0 | $0 | 4 | $321K |
All trades
| Filed | Insider | Type | Value | 3 mo. after |
|---|---|---|---|---|
| Sep 25 | Viviane MongesDirector | ▼ SELL | $396K | |
| Sep 24 | Schikan Johannes Gerardus Christiaan PetrusDirector | ▼ SELL | $29K | |
| Sep 23 | David W. NassifCFO | ▼ SELL | $219K | |
| Sep 21 | Schikan Johannes Gerardus Christiaan PetrusDirector | ▼ SELL | $7.00M | |
| Sep 21 | Peng LuPresident | ▼ SELL | $3.50M | |
| Sep 21 | Elisabeth BjorkDirector | ▼ SELL | $1.99M | |
| Sep 21 | Anne LesageChief Early Development | ▼ SELL | $765K | |
| Sep 21 | Robert GlassmanDirector | ▼ SELL | $559K | |
| Sep 17 | Stefan Andreas AbeleChief Technical Ops Officer | ▼ SELL | $1.77M | |
| Sep 17 | Robert GlassmanDirector | ▼ SELL10b5-1 | $332K | |
| Sep 16 | Wim SouverijnsChief Commercial Officer | ▼ SELL10b5-1 | $786K | |
| Sep 16 | Wim SouverijnsChief Commercial Officer | ▼ SELL10b5-1 | $237K | |
| Sep 15 | Peng LuPresident | ▼ SELL10b5-1 | $602K | |
| Sep 15 | Berndt ModigCEO | ▼ SELL10b5-1 | $90K | |
| Sep 14 | Anne LesageChief Early Development | ▼ SELL10b5-1 | $1.15M | |
| Sep 11 | Robert GlassmanDirector | ▼ SELL10b5-1 | $300K | |
| Sep 9 | Peng LuPresident | ▼ SELL10b5-1 | $610K | |
| Aug 18 | Berndt ModigCEO | ▼ SELL10b5-1 | $80K | |
| Jul 15 | Berndt ModigCEO | ▼ SELL10b5-1 | $80K | |
| Jul 1 | Schikan Johannes Gerardus Christiaan PetrusDirector | ▼ SELL10b5-1 | $1.09M | |
| Jul 1 | Anne LesageChief Early Development | ▼ SELL10b5-1 | $1.09M | |
| Jul 1 | Anne LesageChief Early Development | ▼ SELL10b5-1 | $989K | |
| Jul 1 | Anne LesageChief Early Development | ▼ SELL10b5-1 | $372K | |
| Jul 1 | Anne LesageChief Early Development | ▼ SELL10b5-1 | $245K | |
| Jul 1 | Schikan Johannes Gerardus Christiaan PetrusDirector | ▼ SELL10b5-1 | $241K | |
| Jun 29 | Peng LuChief Medical Officer | ▼ SELL10b5-1 | $519K | |
| Jun 29 | Peng LuChief Medical Officer | ▼ SELL10b5-1 | $500K | |
| Jun 29 | Schikan Johannes Gerardus Christiaan PetrusDirector | ▼ SELL10b5-1 | $84K | |
| Jun 29 | Anne LesageChief Early Development | ▼ SELL10b5-1 | $81K | |
| Jun 29 | Anne LesageChief Early Development | ▼ SELL10b5-1 | $81K | |
| Jun 23 | Peng LuChief Medical Officer | ▼ SELL10b5-1 | $10K | |
| Jun 17 | Berndt ModigCEO | ▼ SELL10b5-1 | $71K |